elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q47374718-D5D56F32-8E04-432A-B32A-E6F4BB39CD05
Q47374718-D5D56F32-8E04-432A-B32A-E6F4BB39CD05
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47374718-D5D56F32-8E04-432A-B32A-E6F4BB39CD05
A novel and selective sodium-glucose cotransporter-2 inhibitor, tofogliflozin, improves glycaemic control and lowers body weight in patients with type 2 diabetes mellitus.
P577
Q47374718-D5D56F32-8E04-432A-B32A-E6F4BB39CD05
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47374718-D5D56F32-8E04-432A-B32A-E6F4BB39CD05
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f3f0a96d722620e99412c4be2e75766f1192b94f
P577
2015-08-20T00:00:00Z
http://www.w3.org/2001/XMLSchema#dateTime
P577
6e7f2f48e4a2f2e2dec1120ae750e056